Oloease Eye Drop contains Olopatadine 0.1% w/v, a selective histamine H1-receptor antagonist with potent anti-allergic properties, indicated for the relief of symptoms associated with allergic conjunctivitis. Olopatadine acts by inhibiting the release of histamine and other mediators from mast cells, thereby reducing itching, redness, and swelling of the conjunctiva. This ophthalmic solution is effective in managing ocular itching caused by seasonal allergic conjunctivitis and vernal keratoconjunctivitis. Oloease Eye Drop provides rapid symptomatic relief and is suitable for adults and children over the age of three years. The formulation is designed for topical application to the eye, ensuring localized action with minimal systemic absorption. It is important to avoid contamination of the dropper tip and to administer the prescribed dosage, typically one drop in the affected eye(s) twice daily or as directed by a healthcare professional. Patients should be advised to remove contact lenses prior to instillation and wait at least 15 minutes before reinsertion. Common side effects may include mild burning or stinging upon application, which generally resolves quickly. Oloease Eye Drop should be used with caution in patients with hypersensitivity to Olopatadine or any component of the formulation.